Roy Winston, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), bought 2,500 shares at $36.50 ($91K) on 2020-03-11, disclosed to the SEC on 2020-03-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | SELL | 2022-08-05 | $27K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $1.9M | — | Filing → |
| PCRX | SELL | 2021-06-08 | $278K | — | Filing → |